INTERNATIONAL PATENT: TILT BIOTHERAPEUTICS OY FILES APPLICATION FOR "ONCOLYTIC ADENOVIRUS, IMMUNE CHECKPOINT INHIBITOR AND CHEMOTERAPEUTIC AGENT COMBINATION THERAPY OF CANCER"

GENEVA, May 12 -- TILT BIOTHERAPEUTICS OY (c/o Biomedicum 2BTukholmankatu 8 B00290 Helsinki) filed a patent application (PCT/FI2024/050592) for "ONCOLYTIC ADENOVIRUS, IMMUNE CHECKPOINT INHIBITOR AND CHEMOTERAPEUTIC AGENT COMBINATION THERAPY OF CANCER" on Nov 04, 2024. With publication no. WO/2025/093824, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JIROVEC, Elise (c/o TILT Biotherapeutics Oyc/o Biomedicum 2BTukholmankatu 8 B00290 Helsinki), QUIXABEIRA, Dafne (c/o TILT Biotherapeutics Oyc/o Biomedicum 2BTukholmankatu 8 ...